NT5C2 and acute lymphoblastic leukemia: Subsequently, extensive research also explored the role of other key enzymes, such as cytosolic 5′-nucleotidase II (NT5C2), which was found to be a significant contributor to thiopurine metabolism and drug resistance, particularly in relapsed ALL [25,26,27,28,29,30,31].